Quick Takeaways: Why It Matters? Merck Animal Health is doubling down on biodevices and automation in poultry by buying TARGAN, turning from a strategic investor into full owner of high-speed sexing and precision vaccination tech Source: Businesswire...
Quick Takeaways: Why It Matters? Ceva is using this deal to cement a differentiated position in swine health by owning Europe’s only commercial vaccine against swine dysentery, a disease that drives major losses in pig production. This will also deepen Ceva’s R&D pipeline and...
Quick Takeaways: Why It Matters? This deal gives Merck Animal Health an early, exclusive window into a gene-therapy pipeline for chronic and age-related diseases in pets, while Rejuvenate Bio secures non-dilutive R&D support and a $6M financing round to advance its platform...
Featured Article Cover Story Product Launches Partnerships & Collaborations Key Industry Themes In This Issue Cosmos Health Expands Into Animal Health Product launch Cosmos Health plans to launch a veterinary version of C-Scrub Wash 4%, expanding its antimicrobial wash brand into anima...
Quick Takeaways Why It Matters? Jaguar is extending its rainforest‑derived GI platform from niche equine/calf use into the much larger companion‑dog market with Neonorm Dog, giving it an OTC, plant‑based gut‑health brand that can sit alongside its prescription Canalevi...
ANIMALHEALTHX Weekly is your weekly pulse on the global animal health industry, delivering curated insights, executive interviews, regulatory updates, innovation breakthroughs, and market movements shaping the future of veterinary medicine and animal care. Cover Story Boehringer Ingel...
Shots: Why It Matters? Designating Wamego as its global HQ formalizes Axiota’s shift from a product-focused business to an integrated innovation hub, anchoring manufacturing, R&D, and scientific operations in the heart of the KC Animal Health Corridor n...
Quick Takeaways: Why It Matters? Darelle’s partnership with Pet Investment uses OneKindly’s fundraising tech to open a new, pet‑focused vertical, creating digital tools that help welfare groups and clinics unlock more financial support for veterinary care. Early ...
Quick Takeaways: Why It Matters? The $100M Symbiotic Capital facility, with $30M already drawn, gives TARGAN flexible, non‑dilutive growth capital, resets its lender base, and underwrites faster global deployment of WingScan at a time when revenues are already more th...
